Justin is a biopharma entrepreneur and early-stage investor committed to moving breakthrough ideas from the lab to the clinic faster.

He leads Axio BioPharma, an AI-driven CDMO that reduces drug-development timelines from years to hours, and he runs Midwest BioCapital, a seed fund backing life-science founders across America’s heartland.

Across both ventures his goal stays the same: help the next wave of therapies reach patients sooner.